SOLU-CORTEF
- Product NDC
- 51662-1262
- Requested package NDC
- 51662-1262-1
- 11-digit product format
- 516621262
- Labeler code
- 51662
- Product ID
- 51662-1262_11ffdbc5-43f8-e2f2-e063-6294a90a43e0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SOLU-CORTEF
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- HF Acquisition Co. LLC, DBA HealthFirst
- Application
- NDA009866
- Marketing category
- NDA
- Marketing start
- 2018-09-03
- Substance
- HYDROCORTISONE SODIUM SUCCINATE
- Active strength
- 250 mg/2mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N009866-001 | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N009866-002 | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | ||
| N009866-003 | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | ||
| N009866-004 | SOLU-CORTEF | HYDROCORTISONE SODIUM SUCCINATE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N009866-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N009866-001 | SOLU-CORTEF | EQ 100MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N009866-002 | SOLU-CORTEF | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N009866-003 | SOLU-CORTEF | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N009866-004 | SOLU-CORTEF | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS, Approved before 1982 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N009866-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N009866-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N009866-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N009866-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N009866-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N009866-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N009866-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N009866-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N009866-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N009866-001 | AP | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N009866-001 | AP | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SOLU-CORTEF
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROCORTISONE SODIUM SUCCINATE | 250 mg/2mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 50LQB69S1Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1738590 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 74f8ccd6-b263-7cc4-e053-2991aa0a896d | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1262-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-63f7-f424-e053-dadaa90a57ce | SOLU-CORTEF® 250mg 2mL ACT-O-VIAL® |
| 51662-1262-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-63f7-f424-e053-dadaa90a57ce | SOLU-CORTEF® 250mg 2mL ACT-O-VIAL® |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1262-1 | SOLU-CORTEF | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 2 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1262 | SOLU-CORTEF INJECTION, POWDER, FOR SOLUTION [HF ACQUISITION CO. LLC, DBA HEALTHFIRST] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240224_74f8ccd6-b263-7cc4-e053-2991aa0a896d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Solu-Cortef | HYDROCORTISONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 65eefd58-b166-4d71-ade6-45c8fdf86922 | 2025-09-05 | Warnings, Adverse reactions | 009866 NDA009866 |
| Solu-Cortef | HYDROCORTISONE SODIUM SUCCINATE | Cardinal Health 107, LLC | f5bb0854-a477-4e59-914b-eeeaef92a596 | 2025-08-21 | Warnings, Adverse reactions | 009866 NDA009866 |
| Solu-Cortef | HYDROCORTISONE SODIUM SUCCINATE | ProPharma Distribution | 386942d3-c75f-25f1-e063-6394a90a5af2 | 2025-07-18 | Warnings, Adverse reactions | 009866 NDA009866 |
| SOLU-CORTEF | SOLU-CORTEF | HF Acquisition Co. LLC, DBA HealthFirst | 74f8ccd6-b263-7cc4-e053-2991aa0a896d | 2024-02-22 | Warnings, Adverse reactions | 009866 NDA009866 51662-1262-1 51662-1262 51662126201 |
| SOLU-CORTEF | SOLU-CORTEF | HF Acquisition Co. LLC, DBA HealthFirst | 74f84173-a43f-7788-e053-2991aa0a8fb2 | 2024-02-22 | Warnings, Adverse reactions | 009866 NDA009866 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1738590 | hydrocortisone sodium succinate 250 MG Injection | PSN | 74f8ccd6-b263-7cc4-e053-2991aa0a896d | 5 |
| 1738590 | hydrocortisone 250 MG Injection | SCD | 74f8ccd6-b263-7cc4-e053-2991aa0a896d | 5 |
| 1738590 | hydrocortisone (as hydrocortisone sodium succinate) 250 MG Injection | SY | 74f8ccd6-b263-7cc4-e053-2991aa0a896d | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51662-1262-1 | 51662126201 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1262-1) | 2 ml | 2018-09-03 | 0000-00-00 | No | No | Current |